<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl200753110-18</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-10911</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая эндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical endocrinology</subject></subj-group></article-categories><title-group><article-title>Корреляция уровня HbA1с и постпрандиальной гликемии в пероральном тесте толерантности к глюкозе у больных сахарным диабетом 2-го типа</article-title><trans-title-group xml:lang="en"><trans-title>Correlation Level of HbA1с and postprandial glycemia in type 2 diabetes in the oral glucose tolerance test</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Древаль</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dreval</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">probl@endojournals.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редькин</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Redkin</surname><given-names>Yu. A.</given-names></name></name-alternatives><email xlink:type="simple">probl@endojournals.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богомолов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogomolov</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">probl@endojournals.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;Московский областной научно-исследовательский клинический институт им. М. Ф. Владимирского&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Moscow Regional Clinical Research Institute named after M.F. Vladimirsky&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>15</day><month>02</month><year>2007</year></pub-date><volume>53</volume><issue>1</issue><issue-title>ТОМ 53, №1 (2007)</issue-title><fpage>10</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Древаль А.В., Редькин Ю.А., Богомолов В.В., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Древаль А.В., Редькин Ю.А., Богомолов В.В.</copyright-holder><copyright-holder xml:lang="en">Dreval A.V., Redkin Y.A., Bogomolov V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/10911">https://www.probl-endojournals.ru/jour/article/view/10911</self-uri><abstract><p>Ряд предложенных на сегодня методов анализа постпрандиальной гликемии в ПТТГ все еще требует обоснования. Стандартный ПТТГ с 75 г глюкозы проведен у 42 больных сахарным диабетом 2-го типа (СД2), получавших диетотерапию. Установлено, что уровень НbАс1с коррелирует с абсолютными уровнями гликемии в ПТТГ через 1 и 2ч. Однако исключение тощаковой гликемии из уровня гликемии через 1 и 2ч в ПТТГ приводит к исчезновению корреляции HbA1с с этими показателями теста. Только 7 из 8 предлагаемых на сегодня параметров вычисления площадей под гликемической кривой в ПТТГ коррелируют с уровнем НbА1с. При этом 5 из этих 7 параметров эквивалентны (r = 1, р &lt; 0,05). Недавно предложенные 2 новых параметра расчета площади под гликемической кривой в ПТТГ, одним из которых является постоянная б, 1, оказались эквивалентными (r=1, р&lt; 0,05) и фактически сводятся к одному. Корреляция с НbА1с сохраняется, если в расчет площади вместо постоянной 6,1 ввести любую другую постоянную в интервале от 5 до 11 ммоль/л, причем самый высокий коэффициент корреляции с НbА1с достигался при значении константы, равном 6,1. Обычно обнаруживаемая при СД2 коррелятивная связь уровня НbА1с абсолютным уровнем постпрандиальной гликемии (гликемический "спайк", в частности) обусловлена прежде всего неявным включением в нее гликемии натощак. При изучении зависимости осложнений сахарного диабета от параметров ПТТГ, которые коррелируют с НbА1с, достаточно использовать комплекс из 4 неэквивалентных параметров ПТТГ. Константы 5,6 и 6,1 отражают разные аспекты развития осложнений при диабете, когда включаются в расчет площади в ПТТГ.</p></abstract><trans-abstract xml:lang="en"><p>A number of today's analytical methods for postprandial glycemia in the oral glucose tolerance test (OGTT) still remain to be substantiated. The standard OGTT using 75 g of glucose was performed in 42 type 2 diabetes mellitus (DM-2) patients who received diet therapy. The concentration of Hb A1c has been found to correlate with absolute levels of glycemia during 1- and 2-hour OGTT. However, exclusion of fasting glycemia from the level of glycemia at 1 and 2 hours of OGTT leads to cession of the correlation of HbA1c with these values of the test. Only 7 out of the 8 today's parameters for calculating the areas under the glycemic curve in OGTT correlate with the level of HbA1c. Moreover, 5 out of these 7 parameters are equivalent (r - 1; p &lt; 0.05). The recently proposed two new parameters for calculating the areas under the glycemic curve in OGTT, one of which is constant 6.1, have proved to be equivalent (r= 1; p &lt; 0 05) and to be actually reduced to one. The correlation with Hb Ah holds if any other constants from 5 to 11 mmоl/l are inserted instead of the constant 6.1 for calculating the area, the highest coefficient correlation with Hb A1c is achieved at the constant equal to 6.1. The correlation usually detectable at DM-2 between the concentration of Hb A,c and the absolute level of postprandial glycemia (glycemic spike in particular) Is mainly determined by its implicit inclusion of fasting glycemia. A set of 4 nonequivalent OGTT parameters should be used when the relationship of diabetes mellitus complications to the OGTT parameters that correlate with HbA,cis studied. The constants 5.6 and 6.1 reflect different aspects of the development of complications in diabetes mellitus when they are included in the calculation of an area in OGTT.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 2-го типа</kwd><kwd>пероральный тест</kwd><kwd>толерантность к глюкозе</kwd><kwd>постпрандиальная глимемия</kwd><kwd>НbА1с</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 2 Diabetes Mellitus</kwd><kwd>ORAL glucose tolerance test</kwd><kwd>postprandial glycemia</kwd><kwd>HbAlc</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Древаль А. В. // Лаб. дело. - 1988. - № 6. - С. 33-38. 2.Древаль А. В, Баташова М. Г. // Пробл. эндокринол. - 1993. - Т. 39, № 3. - С. 13-18.</mixed-citation><mixed-citation xml:lang="en">Древаль А. В. // Лаб. дело. - 1988. - № 6. - С. 33-38. 2.Древаль А. В, Баташова М. Г. // Пробл. эндокринол. - 1993. - Т. 39, № 3. - С. 13-18.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Касаткина Э. П., Odyd Е. А. // Пробл. эндокринол. - 1993. - № 4. - С. 15.</mixed-citation><mixed-citation xml:lang="en">Касаткина Э. П., Odyd Е. А. // Пробл. эндокринол. - 1993. - № 4. - С. 15.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">American College of Endocrinology // Endocr. Pract. - 2002. - Vol. 8. - Suppl. 1. - P. 5-11.</mixed-citation><mixed-citation xml:lang="en">American College of Endocrinology // Endocr. Pract. - 2002. - Vol. 8. - Suppl. 1. - P. 5-11.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association // Diabetes Care. - 2004. - Vol. 27.-P. 5-10.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association // Diabetes Care. - 2004. - Vol. 27.-P. 5-10.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association // Diabetes Care. - 2005. - Vol. 28. - P. 37-42.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association // Diabetes Care. - 2005. - Vol. 28. - P. 37-42.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association // Diabetes Care. - 2003. - Vol. 26. - P. 25-27.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association // Diabetes Care. - 2003. - Vol. 26. - P. 25-27.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association Position Statement // Diabetes Care. - 2004. - Vol. 27. - Suppl. 1. - P. 91-93.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association Position Statement // Diabetes Care. - 2004. - Vol. 27. - Suppl. 1. - P. 91-93.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Avignon A., Radauceanu A., Monnier L. // Diabetes Care. - 1997. - Vol. 20. - P. 1822-1826.</mixed-citation><mixed-citation xml:lang="en">Avignon A., Radauceanu A., Monnier L. // Diabetes Care. - 1997. - Vol. 20. - P. 1822-1826.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bonora E., Calcaterra F., Lombardi S. et al. // Diabetes Care. -2001. - Vol. 24, N 12. - P. 2023-2029.</mixed-citation><mixed-citation xml:lang="en">Bonora E., Calcaterra F., Lombardi S. et al. // Diabetes Care. -2001. - Vol. 24, N 12. - P. 2023-2029.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Breuer H. W. // Int. J. Clin. Pharmacol. Ther. - 2003. - Vol. 41, N 10. - P. 421-440.</mixed-citation><mixed-citation xml:lang="en">Breuer H. W. // Int. J. Clin. Pharmacol. Ther. - 2003. - Vol. 41, N 10. - P. 421-440.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Definition, Diagnosis and Classification of Diabetes Melhtus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Melhtus. World Health Organization Department of Noncommunicable Disease Surveillance. - Geneva, 1999.</mixed-citation><mixed-citation xml:lang="en">Definition, Diagnosis and Classification of Diabetes Melhtus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Melhtus. World Health Organization Department of Noncommunicable Disease Surveillance. - Geneva, 1999.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">The Diabetes Control and Complications Trial Research Group // Diabetes. - 1995. - Vol. 44. - P. 968-983.</mixed-citation><mixed-citation xml:lang="en">The Diabetes Control and Complications Trial Research Group // Diabetes. - 1995. - Vol. 44. - P. 968-983.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gabir M. M., Hanson R. L., Dabelea D. et al. // Diabetes Care. - 2000. - Vol. 23. - P. 1108-1112.</mixed-citation><mixed-citation xml:lang="en">Gabir M. M., Hanson R. L., Dabelea D. et al. // Diabetes Care. - 2000. - Vol. 23. - P. 1108-1112.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kannel W. В., McGee D. L. // J. A. M. A. - 1979. - Vol. 241. - P. 2035-2038.</mixed-citation><mixed-citation xml:lang="en">Kannel W. В., McGee D. L. // J. A. M. A. - 1979. - Vol. 241. - P. 2035-2038.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Laakso M. // Diabetes. - 1999. - Vol. 48. - P. 937-942.</mixed-citation><mixed-citation xml:lang="en">Laakso M. // Diabetes. - 1999. - Vol. 48. - P. 937-942.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Monnler L., Colette C, Rabasa-Lhoret R. et al. // Diabetes Care. - 2002. - Vol. 25. - P. 737-741.</mixed-citation><mixed-citation xml:lang="en">Monnler L., Colette C, Rabasa-Lhoret R. et al. // Diabetes Care. - 2002. - Vol. 25. - P. 737-741.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Monnier L., Laplnskl H., Colette C. // Diabetes Care. - 2003. -Vol. 26. - P. 881-885.</mixed-citation><mixed-citation xml:lang="en">Monnier L., Laplnskl H., Colette C. // Diabetes Care. - 2003. -Vol. 26. - P. 881-885.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mortensen H. В., Volund A. // Scand. J. Clin. Lab. Invest. - 1988.- Vol. 48. - P. 595-602.</mixed-citation><mixed-citation xml:lang="en">Mortensen H. В., Volund A. // Scand. J. Clin. Lab. Invest. - 1988.- Vol. 48. - P. 595-602.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nakashima K., Nishizaki O., Andoh Y. et al. // Clin. Chem. - 1989.- Vol. 35. - P. 958-962.</mixed-citation><mixed-citation xml:lang="en">Nakashima K., Nishizaki O., Andoh Y. et al. // Clin. Chem. - 1989.- Vol. 35. - P. 958-962.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Paoltsso C., Rizzo M. R., Barbieri M. et al. // Diabet. Metab. -2003. - Vol. 29. - P. 335-340.</mixed-citation><mixed-citation xml:lang="en">Paoltsso C., Rizzo M. R., Barbieri M. et al. // Diabet. Metab. -2003. - Vol. 29. - P. 335-340.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Phdlips P. J., Phillipov G. // Aust. Fam. Physician. - 2005. - Vol. 34, N 8. - P. 663-667.</mixed-citation><mixed-citation xml:lang="en">Phdlips P. J., Phillipov G. // Aust. Fam. Physician. - 2005. - Vol. 34, N 8. - P. 663-667.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Soonthompun S., Rattarasam C, Leelawattana R., Setasuban W. // Diabet. Res. Clin. Pract. - 1999. - Vol. 46. - P. 23-27.</mixed-citation><mixed-citation xml:lang="en">Soonthompun S., Rattarasam C, Leelawattana R., Setasuban W. // Diabet. Res. Clin. Pract. - 1999. - Vol. 46. - P. 23-27.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Stratton I. M., Adler A. I., Neil H. A. W. et al. // Br. Med. J. -2000. - Vol. 321. - P. 405-412.</mixed-citation><mixed-citation xml:lang="en">Stratton I. M., Adler A. I., Neil H. A. W. et al. // Br. Med. J. -2000. - Vol. 321. - P. 405-412.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Temelkova-Kurktschiev T. S, Koehler C, Henkel E. et al. // Diabetes Care. - 2000. - Vol. 23, N 12. - P. 1830-1834.</mixed-citation><mixed-citation xml:lang="en">Temelkova-Kurktschiev T. S, Koehler C, Henkel E. et al. // Diabetes Care. - 2000. - Vol. 23, N 12. - P. 1830-1834.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
